Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Iron Deficiency Anemia - Overview
Iron Deficiency Anemia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Iron Deficiency Anemia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Iron Deficiency Anemia - Companies Involved in Therapeutics Development
Akebia Therapeutics Inc
Fe3 Medical Inc
Iron4u Aps
Jiangsu Aosaikang Pharmaceutical Co Ltd
Keros Therapeutics Inc
MegaPro Biomedical Co Ltd
Novartis AG
Panion & Bf Biotech Inc
Pharmacosmos AS
Rockwell Medical Inc
Shield Therapeutics Plc
Silarus Therapeutics Inc
Vifor Pharma Ltd
Iron Deficiency Anemia - Drug Profiles
AKB-5343 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSJ-137 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drug to Replace Iron for Iron Deficiency Anemia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Ferric bepectate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ferric carboxymaltose - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ferric carboxymaltose - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Iron Deficiency Anemia - Dormant Projects
Iron Deficiency Anemia - Discontinued Products
Iron Deficiency Anemia - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Iron Deficiency Anemia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Iron Deficiency Anemia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Iron Deficiency Anemia - Pipeline by Akebia Therapeutics Inc, H2 2020
Iron Deficiency Anemia - Pipeline by Fe3 Medical Inc, H2 2020
Iron Deficiency Anemia - Pipeline by Iron4u Aps, H2 2020
Iron Deficiency Anemia - Pipeline by Jiangsu Aosaikang Pharmaceutical Co Ltd, H2 2020
Iron Deficiency Anemia - Pipeline by Keros Therapeutics Inc, H2 2020
Iron Deficiency Anemia - Pipeline by MegaPro Biomedical Co Ltd, H2 2020
Iron Deficiency Anemia - Pipeline by Novartis AG, H2 2020
Iron Deficiency Anemia - Pipeline by Panion & Bf Biotech Inc, H2 2020
Iron Deficiency Anemia - Pipeline by Pharmacosmos AS, H2 2020
Iron Deficiency Anemia - Pipeline by Rockwell Medical Inc, H2 2020
Iron Deficiency Anemia - Pipeline by Shield Therapeutics Plc, H2 2020
Iron Deficiency Anemia - Pipeline by Silarus Therapeutics Inc, H2 2020
Iron Deficiency Anemia - Pipeline by Vifor Pharma Ltd, H2 2020
Iron Deficiency Anemia - Dormant Projects, H2 2020
Iron Deficiency Anemia - Discontinued Products, H2 2020